15,280 Shares in HCA Healthcare, Inc. (NYSE:HCA) Bought by Hantz Financial Services Inc.

Hantz Financial Services Inc. purchased a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 15,280 shares of the company’s stock, valued at approximately $4,909,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in HCA. Atlantic Edge Private Wealth Management LLC purchased a new position in shares of HCA Healthcare during the 4th quarter valued at $27,000. Bangor Savings Bank lifted its position in shares of HCA Healthcare by 112.5% in the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after acquiring an additional 45 shares in the last quarter. MFA Wealth Advisors LLC bought a new stake in HCA Healthcare during the 2nd quarter valued at approximately $27,000. Unique Wealth Strategies LLC purchased a new stake in HCA Healthcare during the 2nd quarter valued at approximately $28,000. Finally, GPS Wealth Strategies Group LLC lifted its holdings in shares of HCA Healthcare by 284.0% in the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after buying an additional 71 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on HCA shares. JPMorgan Chase & Co. boosted their price target on shares of HCA Healthcare from $327.00 to $332.00 and gave the stock a “neutral” rating in a research report on Thursday, May 30th. Wells Fargo & Company increased their price target on shares of HCA Healthcare from $315.00 to $365.00 and gave the company an “equal weight” rating in a report on Tuesday, July 30th. Oppenheimer raised their price objective on HCA Healthcare from $345.00 to $390.00 and gave the company an “outperform” rating in a research note on Wednesday, July 24th. Truist Financial increased their price target on HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a report on Monday, August 19th. Finally, Robert W. Baird began coverage on shares of HCA Healthcare in a research report on Thursday, May 30th. They set an “outperform” rating and a $396.00 price objective on the stock. Four investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $356.17.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $395.59 on Friday. The stock’s 50-day moving average is $349.74 and its two-hundred day moving average is $333.45. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94. The company has a market cap of $103.61 billion, a price-to-earnings ratio of 19.72, a price-to-earnings-growth ratio of 1.39 and a beta of 1.68. HCA Healthcare, Inc. has a 1-year low of $215.96 and a 1-year high of $395.91.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. The firm had revenue of $17.49 billion during the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The company’s revenue was up 10.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $4.29 earnings per share. Analysts forecast that HCA Healthcare, Inc. will post 22.43 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be issued a dividend of $0.66 per share. The ex-dividend date of this dividend is Monday, September 16th. This represents a $2.64 dividend on an annualized basis and a yield of 0.67%. HCA Healthcare’s payout ratio is currently 13.16%.

Insider Activity

In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the transaction, the senior vice president now owns 17,755 shares in the company, valued at $6,303,912.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, SVP Kathryn A. Torres sold 1,857 shares of the stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the sale, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at $6,303,912.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Christopher F. Wyatt sold 4,000 shares of the company’s stock in a transaction on Monday, July 29th. The shares were sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the completion of the sale, the senior vice president now owns 40,449 shares of the company’s stock, valued at approximately $14,569,729.80. The disclosure for this sale can be found here. In the last quarter, insiders sold 8,844 shares of company stock worth $3,185,932. Corporate insiders own 1.60% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.